Therapy Areas: Autoimmune
20 February 2024 - Clinical stage biotech firm Chemomab Therapeutics Ltd (Nasdaq: CMMB) announced on Tuesday that it has been granted new patents for CM-101, its pioneering monoclonal antibody address...
20 February 2024 - Immunology company argenx SE (Euronext Brussels:ARGX) (Nasdaq:ARGX) reported on Tuesday that the US Food and Drug Administration (FDA) has accepted for priority review a supplementa...
20 February 2024 - Innovent Biologics, Inc. (HKEX: 01801), a China-based biopharmaceutical company that develops, manufactures and commercialises medicines for the treatment of cancer, metabolic, auto...
20 February 2024 - Werfen, a Spain-based company that develops, manufactures and distributes specialised diagnostic instruments, related reagents, automation workcells, and data management solutions f...
15 February 2024 - Swedish biotechnology company Diamyd Medical AB (STO:DMYD-B) announced on Thursday that the US Food and Drug Administration (FDA) has granted Fast Track designation for Diamyd (rhGA...
14 February 2024 - Japanese pharmaceutical company Ono Pharmaceutical Co Ltd (TYO:4528) announced on Wednesday a drug discovery collaboration and option agreement with US clinical-stage biotechnology ...